Abstract
In contrast to epithelial cells, cardiomyocytes are connected by complex hybrid-type adhering junctions, termed composite junctions (areae compositae). Composite junctions are found to be composed of typical desmosomal as well as adherens junction proteins. Therefore, in adult mammalian cardiomyocytes desmosomal proteins are not restricted to the relatively small desmosomes but are indirectly involved in anchoring the myofibrillar actin filaments. Subsequent investigations revealed that the formation of composite junctions is a rather late event during mammalian heart development and vertebrate heart evolution. Nascent, more round shaped cardiomyocytes of early developmental stages are connected by desmosomes and separate adherens junctions quite similar to cells of epithelial origin. During progression of development both types of adhering junctions seem to gradually fuse at the two poles of the mature mammalian cardiomyocytes to establish the hybrid-type composite junctions. Recently, we demonstrated that the specialized cardiomyocytes of the cardiac conduction system exhibit high amounts of desmosomes, not fully established composite junctions and adherens junctions. This underlines the fact that cells of the cardiac conduction system are known to resemble cardiomyocytes in their nascent state and do not undergo working myocardial differentiation. However, the astonishing high amount of desmosomal protein containing adhering junctions connecting, e.g., Purkinje fibers raises the possibility that pacemaker and conductive tissue may be affected by desmosomal gene mutations in ARVC/D patients.
Effects of Mutations in Genes Encoding for Cardiomyocyte Adhering Junction Components
Desmosomes and fasciae adhaerentes (sing., fascia adhaerens), the latter also termed adherens junctions are responsible for cell–cell adhesion and are often subsumed under the collective term adhering junctions. In various epithelia, like in the multistratified skin epithelium, desmosomes, and adherens junctions are distinct structures with only few shared components, such as, e.g., plakoglobin (Cowin et al., 1986). Desmosomes anchor the cytoskeletal intermediate filaments and fasciae adhaerentes the cytoskeletal actin microfilaments (Franke, 2009; Dubash and Green, 2011). In the heart things are quite different and more complex. Adult mammalian cardiomyocytes are for the most part connected by adhering junctions termed areae compositae (sing., area composita) or composite junctions to highlight their hybrid character (Franke et al., 2006, 2009; Pieperhoff et al., 2010a). Composite junctions consist of both, typical desmosomal and typical adherens junction proteins (Franke et al., 2006; Pieperhoff et al., 2010a). In composite junctions desmosomal proteins are therefore indirectly involved in supporting the myofibrillar actin anchorage in N-cadherin mediated cell–cell adhesion complexes (Goossens et al., 2007).
Today it is generally accepted that arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is in most of the cases caused by mutations in desmosomal genes. Disease causing mutations have been found in genes encoding for the desmosomal plaque components plakophilin-2, desmoplakin, and plakoglobin and the transmembrane desmosomal cadherins desmoglein-2 and desmocollin-2 (see, e.g., Rampazzo et al., 2002; Norman et al., 2005; Pilichou et al., 2006; Thiene et al., 2007; for further references please see Rickelt and Pieperhoff, 2012). Although rare, mutations in some non-desmosomal proteins such as, desmin (see Figure 1), transforming growth factor-β3 (TGFB3), transmembrane protein 43 (TMEM43), ryanodine receptor 2 (RYR2), lamins A and C, striatin and titin have also been associated with ARVC/D development (Rampazzo et al., 1995; Beffagna et al., 2005; Merner et al., 2008; Klauke et al., 2010; Meurs et al., 2010; Quarta et al., 2011; Taylor et al., 2011). ARVC/D is characterized by a progressive replacement of contractile heart muscle tissue by fibrotic and fat tissue (“fibrofatty replacement”) and severe arrhythmogenesis often followed by sudden cardiac mortality. Fibrofatty replacement was often but not exclusively found in the right ventricle (Bauce et al., 2005; Lindstrom et al., 2005; Thiene et al., 2007). Homozygous mutations in plakoglobin cause a syndromic disease form called “Naxos disease” involving skin and hair abnormalities in addition to the ARVC/D-type fibrofatty replacement of the myocardium (Protonotarios et al., 2001).
Figure 1
Functional alterations in ARVC/D most likely include alterations in gap junctions and sodium channels as a result from adhering junction defects (Kaplan et al., 2004; Sato et al., 2009, 2011). Furthermore, suppressed Wnt-signaling by nuclear plakoglobin may be involved in fibrofatty replacement and ARVC/D phenotype development (Garcia-Gras et al., 2006; MacRae et al., 2006; Hirschy et al., 2010; Lombardi et al., 2011). In earlier investigations, cell contacts have been found to be an independent factor for cardiomyocyte survival in vitro (Clark et al., 1998) showing the general importance of these structures beside their important role in cell–cell adhesion.
Overexpression of mutant desmosomal genes or introduction of mutant desmosomal genes in mice (Pilichou et al., 2009) and other animal model systems (zebrafish) will help further to understand ARVC/D disease development and treatment (Macrae, 2010; Fabritz et al., 2011).
Recently, screening for novel candidates of ARVC/D causing genes have been for the first time extended to typical fascia adhaerens components, yet without striking results (Christensen et al., 2011). However, many other candidate genes, localized in the composite junctions within the intercalated disk may be included in future screenings (e.g., Kargacin et al., 2006; Otten et al., 2010; Seeger et al., 2010). Hopefully, this will improve molecular diagnostics, genetic testing, and genetic management of this disease (Fressart et al., 2010).
Possible Effects of ARVC/D Causing Gene Mutations on Cells of the Cardiac Conduction System
In the higher vertebrate heart muscle the rhythmic contraction of single cardiomyocytes is secured by a hierarchical system which includes the cardiac conduction system composed of pacemaker and conductive tissue. Pacemaker and conductive tissue consists of specialized cardiomyocytes which did not underwent working myocardial differentiation (Christoffels et al., 2010). Cells of the cardiac conduction system are insulated by connective tissue from the working myocardium in some areas of the heart (see Figure 1; see also, Anderson et al., 2009; Pieperhoff et al., 2010b). Electrical impulses are generated by cells of the sinoatrial (SA) node and travel to the atrioventricular (AV) node (Bakker et al., 2010). The conduction velocity is greatly reduced in the AV node to allow the atrium to contract before the ventricle (Mamlin and Fisch, 1965). The fast conduction system within the ventricle includes the bundles of His (1893), the right and left bundle branches (RBB, LBB) on either side of the ventricular septum and the meshwork of Purkinje fibers (Purkyne, 1845; Tawara, 1906; Shimada et al., 2004; Miquerol et al., 2011).
Pathological alterations in the cardiac conduction system have been described to cause sudden cardiac death before (e.g., Thiene et al., 1983) but never been found nor described in cases of ARVC/D. However, risk stratification of ARVC/D patients using ECG analyses revealed that “prolonged PR interval, prolonged QRS in lead VI, and presence of bundle branch block were predictors for adverse outcome” (Lemola et al., 2005).
Conductive cells have been found to be connected by a relatively high density of desmosomal protein containing desmosomes and composite junctions (Pieperhoff et al., 2010b). Cell contacts of conductive cells resemble adhering junctions of nascent cardiomyocytes (Pieperhoff and Franke, 2007; Pieperhoff et al., 2010b). Desmocollin-2 and desmoplakin (see Figure 2) and all other desmosomal as well as adherens junction components involved in connecting cardiomyocytes can be found in adhering junctions of Purkinje fiber cells (Pieperhoff et al., 2010b). This is why, mutations in desmosomal (and non-desmosomal) genes resulting in the described defects in the myocardium could affect cells of the cardiac conduction system similarly. This could then contribute to severe arrhythmogenesis in ARVC/D patients and may explain why the presence of left bundle branch blocks in ECG analyses has been found to be a predictor for the adverse outcome of the disease (Lemola et al., 2005). Possible disease mechanisms could include cell adhesion defects, alterations in gap junction localization and function, resulting conduction disturbance and fibrofatty replacement of cardiomyocytes of the conduction system as similarly described in cardiomyocytes of the working myocardium (Norgett et al., 2000; Norman et al., 2005; MacRae et al., 2006; Herren et al., 2009; Sato et al., 2011).
Figure 2
Summary and Conclusion
Cardiomyocytes of the working myocardium and of the cardiac conduction system share many similarities. The high abundance of desmosomal protein containing adhering junctions connecting cardiomyocytes of the conduction system raises the possibility that conductive and pacemaker tissue might be affected by desmosomal gene mutations in cases of ARVC/D. Even minor alterations in cells of the cardiac conduction system could contribute to severe arrhythmogenesis in ARVC/D patients.
Statements
Acknowledgments
I thank the German Science Foundation (DFG) for funding of a postdoctoral fellowship (Pi 869/1-1) and the British Heart Foundation (BHF) for subsequent funding within the BHF Centres of Research Excellence (BHF CoRE). Special thanks go to Prof. Werner Franke (German Cancer Research Center, Heidelberg, Germany), Prof. John Mullins, Dr. Martin Denvir, and Dr. Gillian Gray (QMRI, BHF Centre for Cardiovascular Science, Edinburgh, UK), and to Prof. Calum MacRae (Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA) for support and scientific discussions.
Conflict of interest
The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1
AndersonR. H.YanniJ.BoyettM. R.ChandlerN. J.DobrzynskiH. (2009). The anatomy of the cardiac conduction system. Clin. Anat.22, 99–113.10.1002/ca.20700
2
BakkerM. L.MoormanA. F.ChristoffelsV. M. (2010). The atrioventricular node: origin, development, and genetic program. Trends Cardiovasc. Med.20, 164–171.10.1016/j.tcm.2011.02.001
3
BauceB.BassoC.RampazzoA.BeffagnaG.DalientoL.FrigoG.MalacridaS.SettimoL.DanieliG.ThieneG.NavaA. (2005). Clinical profile of four families with arrhythmogenic right ventricular cardiomyopathy caused by dominant desmoplakin mutations. Eur. Heart J.26, 1666–1675.10.1093/eurheartj/ehi341
4
BeffagnaG.OcchiG.NavaA.VitielloL.DitadiA.BassoC.BauceB.CarraroG.ThieneG.TowbinJ. A.DanieliG. A.RampazzoA. (2005). Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. Cardiovasc. Res.65, 366–373.10.1016/j.cardiores.2004.10.005
5
ChristensenA. H.BennM.Tybjaerg-HansenA.HaunsoS.SvendsenJ. H. (2011). Screening of three novel candidate genes in arrhythmogenic right ventricular cardiomyopathy. Genet. Test. Mol. Biomarkers15, 267–271.10.1089/gtmb.2010.0151
6
ChristoffelsV. M.SmitsG. J.KispertA.MoormanA. F. (2010). Development of the pacemaker tissues of the heart. Circ. Res.106, 240–254.10.1161/CIRCRESAHA.109.205419
7
ClarkW. A.DeckerM. L.Behnke-BarclayM.JanesD. M.DeckerR. S. (1998). Cell contact as an independent factor modulating cardiac myocyte hypertrophy and survival in long-term primary culture. J. Mol. Cell. Cardiol.30, 139–155.10.1006/jmcc.1997.0580
8
CowinP.KapprellH. P.FrankeW. W.TamkunJ.HynesR. O. (1986). Plakoglobin: a protein common to different kinds of intercellular adhering junctions. Cell46, 1063–1073.10.1016/0092-8674(86)90706-3
9
DubashA. D.GreenK. J. (2011). Desmosomes. Curr. Biol.21, R529–R531.10.1016/j.cub.2011.04.035
10
FabritzL.HoogendijkM. G.SciclunaB. P.van AmersfoorthS. C.FortmuellerL.WolfS.LaakmannS.KreienkampN.PicciniI.BreithardtG.NoppingerP. R.WittH.EbnetK.WichterT.LevkauB.FrankeW. W.PieperhoffS.de BakkerJ. M.CoronelR.KirchhofP. (2011). Load-reducing therapy prevents development of arrhythmogenic right ventricular cardiomyopathy in plakoglobin-deficient mice. J. Am. Coll. Cardiol.57, 740–750.10.1016/S0735-1097(11)60740-7
11
FrankeW. W. (2009). Discovering the molecular components of intercellular junctions – a historical view. Cold Spring Harb. Perspect. Biol.1, a003061.10.1101/cshperspect.a003061
12
FrankeW. W.BorrmannC. M.GrundC.PieperhoffS. (2006). The area composita of adhering junctions connecting heart muscle cells of vertebrates. I. Molecular definition in intercalated disks of cardiomyocytes by immunoelectron microscopy of desmosomal proteins. Eur. J. Cell Biol.85, 69–82.10.1016/j.ejcb.2006.02.003
13
FrankeW. W.RickeltS.BarthM.PieperhoffS. (2009). The junctions that don’t fit the scheme: special symmetrical cell-cell junctions of their own kind. Cell Tissue Res.338, 1–17.10.1007/s00441-009-0849-z
14
FressartV.DuthoitG.DonalE.ProbstV.DeharoJ. C.ChevalierP.KlugD.DubourgO.DelacretazE.CosnayP.ScanuP.ExtramianaF.KellerD.Hidden-LucetF.SimonF.BessirardV.Roux-BuissonN.HebertJ. L.AzarineA.Casset-SenonD.RouzetF.LecarpentierY.FontaineG.CoiraultC.FrankR.HainqueB.CharronP. (2010). Desmosomal gene analysis in arrhythmogenic right ventricular dysplasia/cardiomyopathy: spectrum of mutations and clinical impact in practice. Europace12, 861–868.10.1093/europace/euq104
15
Garcia-GrasE.LombardiR.GiocondoM. J.WillersonJ. T.SchneiderM. D.KhouryD. S.MarianA. J. (2006). Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy. J. Clin. Invest.116, 2012–2021.10.1172/JCI27751
16
GoossensS.JanssensB.BonneS.De RyckeR.BraetF.van HengelJ.van RoyF. (2007). A unique and specific interaction between alphaT-catenin and plakophilin-2 in the area composita, the mixed-type junctional structure of cardiac intercalated discs. J. Cell Sci.120, 2126–2136.10.1242/jcs.004713
17
HerrenT.GerberP. A.DuruF. (2009). Arrhythmogenic right ventricular cardiomyopathy/dysplasia: a not so rare “disease of the desmosome” with multiple clinical presentations. Clin. Res. Cardiol.98, 141–158.10.1007/s00392-009-0751-4
18
HirschyA.CroqueloisA.PerriardE.SchoenauerR.AgarkovaI.HoerstrupS. P.TaketoM. M.PedrazziniT.PerriardJ. C.EhlerE. (2010). Stabilised beta-catenin in postnatal ventricular myocardium leads to dilated cardiomyopathy and premature death. Basic Res. Cardiol.105, 597–608.10.1007/s00395-010-0101-8
19
HisJ. W. (1893). The story of the atrioventricular bundle with remarks concerning embryonic heart activity with remarks concerning embryonic heart movement in the adult. Arb. Med. Klin. Leipzig4, 289–318.
20
KaplanS. R.GardJ. J.ProtonotariosN.TsatsopoulouA.SpiliopoulouC.AnastasakisA.SquarcioniC. P.McKennaW. J.ThieneG.BassoC.BrousseN.FontaineG.SaffitzJ. E. (2004). Remodeling of myocyte gap junctions in arrhythmogenic right ventricular cardiomyopathy due to a deletion in plakoglobin (Naxos disease). Heart Rhythm1, 3–11.10.1016/j.hrthm.2004.03.002
21
KargacinG. J.HuntD.EmmettT.RokolyaA.McMartinG. A.WirchE.WalshM. P.IkebeM.KargacinM. E. (2006). Localization of telokin at the intercalated discs of cardiac myocytes. Arch. Biochem. Biophys.456, 151–160.10.1016/j.abb.2006.06.018
22
KlaukeB.KossmannS.GaertnerA.BrandK.StorkI.BrodehlA.DiedingM.WalhornV.AnselmettiD.GerdesD.BohmsB.SchulzU.Zu KnyphausenE.VorgerdM.GummertJ.MiltingH. (2010). De novo desmin-mutation N116S is associated with arrhythmogenic right ventricular cardiomyopathy. Hum. Mol. Genet.19, 4595–4607.10.1093/hmg/ddq387
23
LemolaK.BrunckhorstC.HelfensteinU.OechslinE.JenniR.DuruF. (2005). Predictors of adverse outcome in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: long term experience of a tertiary care centre. Heart91, 1167–1172.10.1136/hrt.2004.038620
24
LindstromL.NylanderE.LarssonH.WranneB. (2005). Left ventricular involvement in arrhythmogenic right ventricular cardiomyopathy – a scintigraphic and echocardiographic study. Clin. Physiol. Funct. Imaging25, 171–177.10.1111/j.1475-097X.2005.00607.x
25
LombardiR.da Graca Cabreira-HansenM.BellA.FrommR. R.WillersonJ. T.MarianA. J. (2011). Nuclear plakoglobin is essential for differentiation of cardiac progenitor cells to adipocytes in arrhythmogenic right ventricular cardiomyopathy. Circ. Res.109, 1342–1353.10.1161/CIRCRESAHA.111.255075
26
MacraeC. A. (2010). Cardiac arrhythmia: in vivo screening in the zebrafish to overcome complexity in drug discovery. Expert Opin. Drug Discov.5, 619–632.10.1517/17460441.2010.492826
27
MacRaeC. A.BirchmeierW.ThierfelderL. (2006). Arrhythmogenic right ventricular cardiomyopathy: moving toward mechanism. J. Clin. Invest.116, 1825–1828.10.1172/JCI29174
28
MamlinJ. J.FischC. (1965). Sustained atrioventricular conduction delay due to interpolated ventricular premature systole. Am. J. Cardiol.16, 765–766.10.1016/0002-9149(65)90065-2
29
MernerN. D.HodgkinsonK. A.HaywoodA. F.ConnorsS.FrenchV. M.DrenckhahnJ. D.KupprionC.RamadanovaK.ThierfelderL.McKennaW.GallagherB.Morris-LarkinL.BassettA. S.ParfreyP. S.YoungT. L. (2008). Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene. Am. J. Hum. Genet.82, 809–821.10.1016/j.ajhg.2008.01.010
30
MeursK. M.MauceliE.LahmersS.AclandG. M.WhiteS. N.Lindblad-TohK. (2010). Genome-wide association identifies a deletion in the 3’ untranslated region of striatin in a canine model of arrhythmogenic right ventricular cardiomyopathy. Hum. Genet.128, 315–324.10.1007/s00439-010-0855-y
31
MiquerolL.BeyerS.KellyR. G. (2011). Establishment of the mouse ventricular conduction system. Cardiovasc. Res.91, 232–242.10.1093/cvr/cvr069
32
NorgettE. E.HatsellS. J.Carvajal-HuertaL.CabezasJ. C.CommonJ.PurkisP. E.WhittockN.LeighI. M.StevensH. P.KelsellD. P. (2000). Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma. Hum. Mol. Genet.9, 2761–2766.10.1093/hmg/9.18.2761
33
NormanM.SimpsonM.MogensenJ.ShawA.HughesS.SyrrisP.Sen-ChowdhryS.RowlandE.CrosbyA.McKennaW. J. (2005). Novel mutation in desmoplakin causes arrhythmogenic left ventricular cardiomyopathy. Circulation112, 636–642.10.1161/CIRCULATIONAHA.104.532234
34
OttenJ.van der VenP. F.VakeelP.EulitzS.KirfelG.BrandauO.BoeslM.SchrickelJ. W.LinhartM.HayessK.NayaF. J.MiltingH.MeyerR.FurstD. O. (2010). Complete loss of murine Xin results in a mild cardiac phenotype with altered distribution of intercalated discs. Cardiovasc. Res.85, 739–750.10.1093/cvr/cvp345
35
PieperhoffS.BarthM.RickeltS.FrankeW. W. (2010a). “Desmosomal molecules in and out of adhering junctions: normal and diseased states of epidermal, cardiac and mesenchymally derived cells,”Desmosomes and Desmosomal Cadherin Function in Skin and Heart Diseases – Advancements in Basic and Clinical Research,” eds MahoneyM. G.MüllerE. J.KochP. J. (New York: Hindawi), 11.
36
PieperhoffS.BorrmannC. M.GrundC.BarthM.RizzoS.FrankeW. W. (2010b). The area composita of adhering junctions connecting heart muscle cells of vertebrates. VII. The different types of lateral junctions between the special cardiomyocytes of the conduction system of ovine and bovine hearts. Eur. J. Cell Biol.89, 365–378.10.1016/j.ejcb.2009.11.025
37
PieperhoffS.FrankeW. W. (2007). The area composita of adhering junctions connecting heart muscle cells of vertebrates. IV. Coalescence and amalgamation of desmosomal and adhaerens junction components – late processes in mammalian heart development. Eur. J. Cell Biol.86, 377–391.10.1016/j.ejcb.2007.04.001
38
PilichouK.NavaA.BassoC.BeffagnaG.BauceB.LorenzonA.FrigoG.VettoriA.ValenteM.TowbinJ.ThieneG.DanieliG. A.RampazzoA. (2006). Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy. Circulation113, 1171–1179.10.1161/CIRCULATIONAHA.105.583674
39
PilichouK.RemmeC. A.BassoC.CampianM. E.RizzoS.BarnettP.SciclunaB. P.BauceB.van den HoffM. J.de BakkerJ. M.TanH. L.ValenteM.NavaA.WildeA. A.MoormanA. F.ThieneG.BezzinaC. R. (2009). Myocyte necrosis underlies progressive myocardial dystrophy in mouse dsg2-related arrhythmogenic right ventricular cardiomyopathy. J. Exp. Med.206, 1787–1802.10.1084/jem.20090641
40
ProtonotariosN.TsatsopoulouA.FontaineG. (2001). Naxos disease: keratoderma, scalp modifications, and cardiomyopathy. J. Am. Acad. Dermatol.44, 309–311.10.1067/mjd.2001.110648
41
PurkyneJ. E. (1845). Mikroskopisch-neurologische Beobachtungen. Arch. Anat. Physiol. Wiss. Med.12, 281–295.
42
QuartaG.SyrrisP.AshworthM.JenkinsS.Zuborne AlapiK.MorganJ.MuirA.PantazisA.McKennaW. J.ElliottP. M. (2011). Mutations in the Lamin A/C gene mimic arrhythmogenic right ventricular cardiomyopathy. Eur. Heart J. [Epub ahead of print].10.1093/eurheartj/ehr1451
43
RampazzoA.NavaA.ErneP.EberhardM.VianE.SlompP.TisoN.ThieneG.DanieliG. A. (1995). A new locus for arrhythmogenic right ventricular cardiomyopathy (ARVD2) maps to chromosome 1q42-q43. Hum. Mol. Genet.4, 2151–2154.10.1093/hmg/4.11.2151
44
RampazzoA.NavaA.MalacridaS.BeffagnaG.BauceB.RossiV.ZimbelloR.SimionatiB.BassoC.ThieneG.TowbinJ. A.DanieliG. A. (2002). Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. Am. J. Hum. Genet.71, 1200–1206.10.1086/344208
45
RickeltS.PieperhoffS. (2012). Mutations with pathogenic potential in proteins located in or at the composite junctions of the intercalated disk connecting mammalian cardiomyocytes: a reference thesaurus for arrhythmogenic cardiomyopathies as well as Naxos and Carvajal diseases. Cell Tiss. Res.10.1007/s00441-012-1365-0
46
SatoP. Y.CoombsW.LinX.NekrasovaO.GreenK. J.IsomL. L.TaffetS. M.DelmarM. (2011). Interactions between ankyrin-g, plakophilin-2, and connexin43 at the cardiac intercalated disc. Circ. Res.109, 193–201.10.1161/CIRCRESAHA.111.247023
47
SatoP. Y.MusaH.CoombsW.Guerrero-SernaG.PatinoG. A.TaffetS. M.IsomL. L.DelmarM. (2009). Loss of plakophilin-2 expression leads to decreased sodium current and slower conduction velocity in cultured cardiac myocytes. Circ. Res.105, 523–526.10.1161/CIRCRESAHA.109.201418
48
SeegerT. S.FrankD.RohrC.WillR.JustS.GrundC.LyonR.LuddeM.KoeglM.SheikhF.RottbauerW.FrankeW. W.KatusH. A.OlsonE. N.FreyN. (2010). Myozap, a novel intercalated disc protein, activates serum response factor-dependent signaling and is required to maintain cardiac function in vivo. Circ. Res.106, 880–890.10.1161/CIRCRESAHA.109.213256
49
ShimadaT.KawazatoH.YasudaA.OnoN.SuedaK. (2004). Cytoarchitecture and intercalated disks of the working myocardium and the conduction system in the mammalian heart. Anat. Rec. A Discov. Mol. Cell. Evol. Biol.280, 940–951.10.1002/ar.a.20109
50
TawaraS. (1906). Das Reizleitungssystem des Säugetierherzens. Eine anatomisch-histologische Studie über das Atrioventrikularbündel und die Purkinjeschen Fäden. Jena: Verlag von Gustav Fisher.
51
TaylorM.GrawS.SinagraG.BarnesC.SlavovD.BrunF.PinamontiB.SalcedoE. E.SauerW.PyxarasS.AndersonB.SimonB.BogomolovasJ.LabeitS.GranzierH.MestroniL. (2011). Genetic variation in titin in arrhythmogenic right ventricular cardiomyopathy-overlap syndromes. Circulation124, 876–885.10.1161/CIRCULATIONAHA.111.054916
52
ThieneG.CorradoD.BassoC. (2007). Arrhythmogenic right ventricular cardiomyopathy/dysplasia. Orphanet. J. Rare Dis.2, 45.10.1186/1750-1172-2-45
53
ThieneG.PennelliN.RossiL. (1983). Cardiac conduction system abnormalities as a possible cause of sudden death in young athletes. Hum. Pathol.14, 707–709.10.1016/S0046-8177(83)80143-9
Summary
Keywords
desmosome, area composita, heart, desmosomal gene mutation, conduction system, ARVC/D
Citation
Pieperhoff S (2012) Gene Mutations Resulting in the Development of ARVC/D Could Affect Cells of the Cardiac Conduction System. Front. Physio. 3:22. doi: 10.3389/fphys.2012.00022
Received
05 January 2012
Accepted
30 January 2012
Published
17 February 2012
Volume
3 - 2012
Edited by
Ruben Coronel, Academic Medical Center, Netherlands
Reviewed by
Bas Boukens, Academic Medical Center, Netherlands; Tamara Koopmann, Academic Medical Center, Netherlands
Copyright
© 2012 Pieperhoff.
This is an open-access article distributed under the terms of the Creative Commons Attribution Non Commercial License, which permits non-commercial use, distribution, and reproduction in other forums, provided the original authors and source are credited.
*Correspondence: Sebastian Pieperhoff, British Heart Foundation Centre for Cardiovascular Science, Queen’s Medical Research Institute, University of Edinburgh, 47 Little France Crescent, Edinburgh, Scotland, UK. e-mail: s.pieperhoff@gmail.com
This article was submitted to Frontiers in Cardiac Electrophysiology, a specialty of Frontiers in Physiology.
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.